News and Events

EINDHOVEN, the Netherlands — July 9, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announcesa publication in Neuromodulation: Technology at the Neural Interface,summarizing effective stimulation parameters from the Up-LIFT and LIFT Home studies and providing a decision-making framework for clinical implementation of ONWARD ARC-EX Therapy created by study investigators.

EINDHOVEN, the Netherlands — June 28, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announces today that the Company and its subsidiaries, ONWARD Medical Inc. and ONWARD Medical S.A., signed a loan agreement in the amount of up to €52.5 million (the “Loan Agreement”) with US-based lender Runway Growth Capital LLC (the “Lender”).

EINDHOVEN, the Netherlands — June 26, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces its participation in the Stifel European Healthcare Summit in Lyon, France from June 25-27th.

EINDHOVEN, the Netherlands — June 18, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that the Company will be highlighted in a main stage keynote at HLTH Europe, a premier event for digital health leaders.